Estimating the Use of Resources and the Costs of Treating Patients With Asthma in the Autonomous Community of Valencia

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
AstraZeneca
ClinicalTrials.gov Identifier:
NCT01114906
First received: April 20, 2010
Last updated: September 16, 2011
Last verified: September 2011

April 20, 2010
September 16, 2011
September 2010
June 2011   (final data collection date for primary outcome measure)
Direct and indirect Resource Use of Asthma patients in 12 months [ Time Frame: Once the patient has been included data refered to the previous 12 month following-up period will be recorded. Thus, all data will be recorded at that time-period. Only one data recording will be done. ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01114906 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Estimating the Use of Resources and the Costs of Treating Patients With Asthma in the Autonomous Community of Valencia
Estimating the Use of Resources and the Costs of Treating Patients With Asthma in the Autonomous Community of Valencia

This study has been conceived in the context of Health Outcomes Research where the outcomes of health interventions in routine clinical practice constitute the main objective of the research process. In the case of asthma in Spain, the investigators do not clearly know the use of resources generated by the patient with asthma, its impact on the effectiveness of the current approach of asthmatic patients and the overall efficiency of health interventions on asthmatic patients. This observational, retrospective and multicenter study aims to estimate the use of health care resources in managing patients with asthma and to determine the management of the disease in the usual clinical practice in Valencia Autonomous Region. The data will be obtained at primary care level from the Electronic Health Record SIA+GAIA data base and at hospital level from allergologists and pneumologists clinical records. The investigators plan to introduce 289 ambulatory patients followed-up in Primary or Specialized Care Services, older than 15 years of age, diagnosed of asthma at least one year before the beginning of the study. The inclusion period will be of 3 months and the retrospective data of 12 previous months of follow-up will be collected.

The direct and indirect use of resources will be collected in order to estimate the management and use of health care resources in managing patients with asthma in the Autonomous region of Valencia as primary endpoint and also to estimate the mean cost of asthmatic patient healthcare; to determine the global effectiveness and the efficiency of the actual asthmatic patient healthcare and to model the health budget according to different objectives of effectiveness for the next five years.

Not Provided
Observational
Time Perspective: Retrospective
Not Provided
Not Provided
Probability Sample

Ambulatory patients followed-up in Primary or Specialized Care Services (hospital)

  • Asthma
  • Valencia Autonomous Region
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
292
June 2011
June 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Ambulatory patients (Primary and Specialized Care)
  • Patients with a diagnose of asthma in the Outpatients' Electronic Health Record [Historia Clínica Ambulatoria electrónica (SIA + GAIA) database

Exclusion Criteria:

  • Patients who have participated in a clinical trial in the last 12 months.
Both
15 Years and older
No
Contact information is only displayed when the study is recruiting subjects
Spain
 
NCT01114906
NIS-RES-DUM-2010/1
No
AstraZeneca
AstraZeneca
Not Provided
Not Provided
AstraZeneca
September 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP